Epigallocatechin gallate suppresses peritoneal fibrosis in mice

Chemico-Biological Interactions

Volumn 195, Issue 1, 2012, Pages 95-104

  Kitamura, Mineaki ^a   Nishino, Tomoya ^a   Obata, Yoko ^a,b   Furusu, Akira ^a   Hishikawa, Yoshitaka ^a,c   Koji, Takehiko ^a   Kohno, Shigeru ^a  

^a NAGASAKI UNIVERSITY   (Japan)

^b NAGASAKI UNIVERSITY HOSPITAL   (Japan)

^c UNIVERSITY OF MIYAZAKI   (Japan)

Author keywords

( ) Epigallocatechin gallate (EGCG); Angiogenesis; Inflammation; Methylglyoxal (MGO); Peritoneal dialysis (PD); Peritoneal fibrosis

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; ALPHA SMOOTH MUSCLE ACTIN; CD31 ANTIGEN; EPIGALLOCATECHIN GALLATE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; METHYLGLYOXAL; MONOCYTE CHEMOTACTIC PROTEIN 1; PERITONEAL DIALYSIS FLUID; REACTIVE OXYGEN METABOLITE; SODIUM CHLORIDE; TRANSFORMING GROWTH FACTOR BETA; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL; CELL COUNT; CONTROLLED STUDY; DRUG MECHANISM; INFLAMMATION; INHIBITION KINETICS; MACROPHAGE; MALE; MOUSE; NONHUMAN; PERITONEAL FIBROSIS; PERITONEUM; SOUTHWESTERN BLOTTING; SUBMESOTHELIAL COMPACT ZONE; THICKNESS;

ANIMALS; ANTIGENS, CD31; CATECHIN; CHEMOKINE CCL2; DIALYSIS SOLUTIONS; INFLAMMATION; MALE; MICE; MICE, INBRED C57BL; NEOVASCULARIZATION, PHYSIOLOGIC; NF-KAPPA B; PERITONEAL FIBROSIS; PERITONEUM; PYRUVALDEHYDE; REACTIVE OXYGEN SPECIES; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

MUS;

EID: 82955217764     PISSN: 00092797     EISSN: 18727786     Source Type: Journal    
DOI: 10.1016/j.cbi.2011.11.002     Document Type: Article

References (45)

1. J.D. Williams, K.J. Craig, N. Topley, C. Von Ruhland, M. Fallon, G.R. Newman, R.K. Mackenzie, and G.T. Williams Morphologic changes in the peritoneal membrane of patients with renal disease Journal of the American Society of Nephrology 13 2 2002 470 479 (Pubitemid 34106290)
2. V.C. Gandhi, H.M. Humayun, T.S. Ing, J.T. Daugirdas, V.R. Jablokow, S. Iwatsuki, W.P. Geis, and J.E. Hano Sclerotic thickening of the peritoneal membrane in maintenance peritoneal dialysis patients Archives of Internal Medicine 140 9 1980 1201 1203 (Pubitemid 10048816)
3. S. Shaw, M. Akyol, J. Bell, J.D. Briggs, and M.H. Dominiczak Effects of continuous ambulatory peritoneal dialysis and kidney transplantation on advanced glycation endproducts in the skin and peritoneum Cellular and Molecular Biology (Noisy-le-Grand, France) 44 7 1998 1061 1068
4. E. Boulanger, N. Grossin, M.P. Wautier, R. Taamma, and J.L. Wautier Mesothelial RAGE activation by AGEs enhances VEGF release and potentiates capillary tube formation Kidney International 71 2 2007 126 133 (Pubitemid 46094685)
5. T. Oya, N. Hattori, Y. Mizuno, S. Miyata, S. Maeda, T. Osawa, and K. Uchida Methylglyoxal modification of protein. Chemical and immunochemical characterization of methylglyoxal-arginine adducts The Journal of Biological Chemistry 274 26 1999 18492 18502
6. K. Honda, K. Nitta, S. Horita, W. Yumura, H. Nihei, R. Nagai, K. Ikeda, and S. Horiuchi Accumulation of advanced glycation end products in the peritoneal vasculature of continuous ambulatory peritoneal dialysis patients with low ultra-filtration Nephrology, Dialysis, Transplantation 14 6 1999 1541 1549 (Pubitemid 29241752)
7. M. Nakayama, A. Sakai, M. Numata, and T. Hosoya Hyper-vascular change and formation of advanced glycation endproducts in the peritoneum caused by methylglyoxal and the effect of an anti-oxidant, sodium sulfite American Journal of Nephrology 23 6 2003 390 394 (Pubitemid 37465100)
8. M. Nakayama, Y. Kawaguchi, K. Yamada, T. Hasegawa, K. Takazoe, N. Katoh, H. Hayakawa, N. Osaka, H. Yamamoto, A. Ogawa, H. Kubo, T. Shigematsu, O. Sakai, and S. Horiuchi Immunohistochemical detection of advanced glycosylation end-products in the peritoneum and its possible pathophysiological role in CAPD Kidney International 51 1 1997 182 186 (Pubitemid 27064536)
9. A. Goldin, J.A. Beckman, A.M. Schmidt, and M.A. Creager Advanced glycation end products: sparking the development of diabetic vascular injury Circulation 114 6 2006 597 605 (Pubitemid 44199649)
10. A.S. De Vriese, A. Flyvbjerg, S. Mortier, R.G. Tilton, and N.H. Lameire Inhibition of the interaction of AGE-RAGE prevents hyperglycemia-induced fibrosis of the peritoneal membrane Journal of the American Society of Nephrology 14 8 2003 2109 2118 (Pubitemid 36909919)
11. S.H. Park, E.G. Lee, I.S. Kim, Y.J. Kim, D.K. Cho, and Y.L. Kim Effect of glucose degradation products on the peritoneal membrane in a chronic inflammatory infusion model of peritoneal dialysis in the rat Peritoneal Dialysis International 24 2 2004 115 122
12. S. Yamagishi, T. Matsui, K. Nakamura, H. Inoue, M. Takeuchi, S. Ueda, K. Fukami, S. Okuda, and T. Imaizumi Olmesartan blocks advanced glycation end products (AGEs)-induced angiogenesis in vitro by suppressing receptor for AGEs (RAGE) expression Microvascular Research 75 1 2008 130 134 (Pubitemid 350266734)
13. L.P. Kihm, D. Wibisono, S. Muller-Krebs, F. Pfisterer, C. Morath, M.L. Gross, M. Morcos, Y. Seregin, A. Bierhaus, P.P. Nawroth, M. Zeier, and V. Schwenger RAGE expression in the human peritoneal membrane Nephrology, Dialysis, Transplantation 23 10 2008 3302 3306
14. I. Hirahara, E. Kusano, S. Yanagiba, Y. Miyata, Y. Ando, S. Muto, and Y. Asano Peritoneal injury by methylglyoxal in peritoneal dialysis Peritoneal Dialysis International 26 3 2006 380 392 (Pubitemid 44340008)
15. Y. Yoshio, M. Miyazaki, K. Abe, T. Nishino, A. Furusu, Y. Mizuta, T. Harada, Y. Ozono, T. Koji, and S. Kohno TNP-470, an angiogenesis inhibitor, suppresses the progression of peritoneal fibrosis in mouse experimental model Kidney International 66 4 2004 1677 1685 (Pubitemid 39298405)
16. K. Fukami, S. Ueda, S. Yamagishi, S. Kato, Y. Inagaki, M. Takeuchi, Y. Motomiya, R. Bucala, S. Iida, K. Tamaki, T. Imaizumi, M.E. Cooper, and S. Okuda AGEs activate mesangial TGF-beta-Smad signaling via an angiotensin II type I receptor interaction Kidney International 66 6 2004 2137 2147 (Pubitemid 41115277)
17. N. Khan, F. Afaq, M. Saleem, N. Ahmad, and H. Mukhtar Targeting multiple signaling pathways by green tea polyphenol (-)-epigallocatechin-3-gallate Cancer Research 66 5 2006 2500 2505
18. N. Khan, and H. Mukhtar Multitargeted therapy of cancer by green tea polyphenols Cancer Letters 269 2 2008 269 280
19. Z. Rasheed, A.N. Anbazhagan, N. Akhtar, S. Ramamurthy, F.R. Voss, and T.M. Haqqi Green tea polyphenol epigallocatechin-3-gallate inhibits advanced glycation end product-induced expression of tumor necrosis factor-alpha and matrix metalloproteinase-13 in human chondrocytes Arthritis Research & Therapy 11 3 2009 R71
20. Y. Yasuda, M. Shimizu, H. Sakai, J. Iwasa, M. Kubota, S. Adachi, Y. Osawa, H. Tsurumi, Y. Hara, and H. Moriwaki (-)-Epigallocatechin gallate prevents carbon tetrachloride-induced rat hepatic fibrosis by inhibiting the expression of the PDGFRbeta and IGF-1R Chemico-biological Interactions 182 2-3 2009 159 164
21. N. Sriram, S. Kalayarasan, and G. Sudhandiran Epigallocatechin-3-gallate exhibits anti-fibrotic effect by attenuating bleomycin-induced glycoconjugates, lysosomal hydrolases and ultrastructural changes in rat model pulmonary fibrosis Chemico-biological Interactions 180 2 2009 271 280
22. H.L. Li, Y. Huang, C.N. Zhang, G. Liu, Y.S. Wei, A.B. Wang, Y.Q. Liu, R.T. Hui, C. Wei, G.M. Williams, D.P. Liu, and C.C. Liang Epigallocathechin-3 gallate inhibits cardiac hypertrophy through blocking reactive oxidative species-dependent and -independent signal pathways Free Radical Biology & Medicine 40 10 2006 1756 1775
23. T. Nishino, M. Miyazaki, K. Abe, A. Furusu, Y. Mishima, T. Harada, Y. Ozono, T. Koji, and S. Kohno Antisense oligonucleotides against collagen-binding stress protein HSP47 suppress peritoneal fibrosis in rats Kidney International 64 3 2003 887 896 (Pubitemid 37013824)
24. Y. Tan, J.S. Zhang, and L. Huang Codelivery of NF-kappaB decoy-related oligodeoxynucleotide improves LPD-mediated systemic gene transfer Molecular Therapy 6 6 2002 804 812 (Pubitemid 36054313)
25. T. Koji, K. Komuta, M. Nozawa, S. Yamada, and P.K. Nakane Localization of cyclic adenosine 3′, 5′-monophosphate-responsive element (CRE)-binding proteins by southwestern histochemistry Journal of Histochemistry and Cytochemistry 42 10 1994 1399 1405 (Pubitemid 24307731)
26. Y. Hishikawa, E. Damavandi, S. Izumi, and T. Koji Molecular histochemical analysis of estrogen receptor alpha and beta expressions in the mouse ovary: in situ hybridization and Southwestern histochemistry Medical Electron Microscopy 36 2 2003 67 73 (Pubitemid 36898471)
27. M. Ashizawa, M. Miyazaki, K. Abe, A. Furusu, H. Isomoto, T. Harada, Y. Ozono, H. Sakai, T. Koji, and S. Kohno Detection of nuclear factor-kappaB in IgA nephropathy using Southwestern histochemistry American Journal of Kidney Diseases 42 1 2003 76 86 (Pubitemid 36813986)
28. F. Perfumo, P. Altieri, M.L. Degl'Innocenti, G.M. Ghiggeri, G. Caridi, A. Trivelli, and R. Gusmano Effects of peritoneal effluents on mesothelial cells in culture: cell proliferation and extracellular matrix regulation Nephrology, Dialysis, Transplantation 11 9 1996 1803 1809 (Pubitemid 26297567)
29. Y. Mishima, M. Miyazaki, K. Abe, Y. Ozono, K. Shioshita, Z. Xia, T. Harada, T. Taguchi, T. Koji, and S. Kohno Enhanced expression of heat shock protein 47 in rat model of peritoneal fibrosis Peritoneal Dialysis International 23 1 2003 14 22 (Pubitemid 36348155)
30. A. Leask Potential therapeutic targets for cardiac fibrosis: TGFbeta, angiotensin, endothelin, CCN2, and PDGF, partners in fibroblast activation Circulation Research 106 11 2010 1675 1680
31. I. Ishida, C. Kohda, Y. Yanagawa, H. Miyaoka, and T. Shimamura Epigallocatechin gallate suppresses expression of receptor activator of NF-kappaB ligand (RANKL) in Staphylococcus aureus infection in osteoblast-like NRG cells Journal of Medical Microbiology 56 Pt 8 2007 1042 1046 (Pubitemid 47262665)
32. S.J. Kim, H.J. Jeong, K.M. Lee, N.Y. Myung, N.H. An, W.M. Yang, S.K. Park, H.J. Lee, S.H. Hong, H.M. Kim, and J.Y. Um Epigallocatechin-3-gallate suppresses NF-kappaB activation and phosphorylation of p38 MAPK and JNK in human astrocytoma U373MG cells The Journal of Nutritional Biochemistry 18 9 2007 587 596
33. M.A. Mateijsen, A.C. van der Wal, P.M. Hendriks, M.M. Zweers, J. Mulder, D.G. Struijk, and R.T. Krediet Vascular and interstitial changes in the peritoneum of CAPD patients with peritoneal sclerosis Peritoneal Dialysis International 19 6 1999 517 525 (Pubitemid 30015564)
34. I. Hirahara, Y. Ishibashi, S. Kaname, E. Kusano, and T. Fujita Methylglyoxal induces peritoneal thickening by mesenchymal-like mesothelial cells in rats Nephrology, Dialysis, Transplantation 24 2 2009 437 447
35. J.L. Wautier, and P.J. Guillausseau Diabetes, advanced glycation endproducts and vascular disease Vascular Medicine (London, England) 3 2 1998 131 137
36. M. Nomura, W. Ma, N. Chen, A.M. Bode, and Z. Dong Inhibition of 12-O-tetradecanoylphorbol-13-acetate-induced NF-kappaB activation by tea polyphenols, (-)-epigallocatechin gallate and theaflavins Carcinogenesis 21 10 2000 1885 1890
37. F. Afaq, V.M. Adhami, N. Ahmad, and H. Mukhtar Inhibition of ultraviolet B-mediated activation of nuclear factor kappaB in normal human epidermal keratinocytes by green tea Constituent (-)-epigallocatechin-3-gallate Oncogene 22 7 2003 1035 1044 (Pubitemid 36313147)
38. Z. Dong Effects of food factors on signal transduction pathways BioFactors (Oxford, England) 12 1-4 2000 17 28 (Pubitemid 32107380)
39. T. Walle Absorption and metabolism of flavonoids Free Radical Biology & Medicine 36 7 2004 829 837 (Pubitemid 38401062)
40. J.D. Lambert, M.J. Lee, H. Lu, X. Meng, J.J. Hong, D.N. Seril, M.G. Sturgill, and C.S. Yang Epigallocatechin-3-gallate is absorbed but extensively glucuronidated following oral administration to mice The Journal of Nutrition 133 12 2003 4172 4177 (Pubitemid 37505494)
41. J.D. Lambert, D.H. Kim, R. Zheng, and C.S. Yang Transdermal delivery of (-)-epigallocatechin-3-gallate, a green tea polyphenol, in mice The Journal of Pharmacy and Pharmacology 58 5 2006 599 604
42. C.H. Wu, and G.C. Yen Inhibitory effect of naturally occurring flavonoids on the formation of advanced glycation endproducts Journal of Agricultural and Food Chemistry 53 8 2005 3167 3173
43. H. Mukhtar, and N. Ahmad Tea polyphenols: prevention of cancer and optimizing health The American Journal of Clinical Nutrition 71 6 Suppl. 2000 1698S 1702S
44. R.A. Isbrucker, J.A. Edwards, E. Wolz, A. Davidovich, and J. Bausch Safety studies on epigallocatechin gallate (EGCG) preparations. Part 3: teratogenicity and reproductive toxicity studies in rats Food and Chemical Toxicology 44 5 2006 651 661
45. J.D. Lambert, M.J. Kennett, S. Sang, K.R. Reuhl, J. Ju, and C.S. Yang Hepatotoxicity of high oral dose (-)-epigallocatechin-3-gallate in mice Food and Chemical Toxicology 48 1 2010 409 416